J Gen Virol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 77 (1996), 2097-2108; DOI 10.1099/0022-1317-77-9-2097
© 1996 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cello, J.
Right arrow Articles by Svennerholm, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cello, J.
Right arrow Articles by Svennerholm, B.
Agricola
Right arrow Articles by Cello, J.
Right arrow Articles by Svennerholm, B.

A Study of the Cellular Immune Response to Enteroviruses in Humans: Identification of Cross-reactive T Cell Epitopes on the Structural Proteins of Enteroviruses

Jeronimo Cello, Örjan Strannegård and Bo Svennerholm

Department of Clinical Virology, Faculty of Medicine, University of Göteborg, Guldhedsgatan 10-B, S-413 46 Göteborg, Sweden

Author for correspondence: Jeronimo Cello. Present Address: Instituto Nacional de Microbiología, Dr. Carlos G. Malbran, Av. Velez Sarsfield 563, (1281 ) Buenos Aires, Argentina.Fax + 54 1 3031801, e-mail virus{at}malbra.sld.ar

We have attempted to extend our understanding of the enteroviral cross-reactive T cell response in humans. Peripheral blood mononuclear cells (PBMC) from healthy donors were stimulated in vitro with six different serotypes of enterovirus and 15 synthetic peptides representing conserved regions in the four structural proteins of these viruses. Upon challenge with different antigens, PBMC from donors responded specifically with proliferation and production of interferon-{gamma} (IFN-{gamma}). In contrast, synthesis of interleukin-4 (IL-4) or IL-10 was not detected. A T cell response to each enterovirus serotype was recorded in all individuals even though not all individuals had serum neutralizing antibody against each virus. These data confirmed previous findings that human T cells recognize enteroviral cross-reactive epitopes. Analysis of the peptide-induced IFN-{gamma} production and proliferative response showed that the cross-reactive T cell epitopes are localized mainly in capsid protein VP2 and VP3 and to a lesser extent in VP1. Surprisingly, T cell epitopes were not identified in the most conserved structural protein of enterovirus, VP4. Immune responses were mediated by CD4+ T cells in association with MHC class II molecules. The sources of IFN-{gamma} in response to the most immunodominant cross-reactive T cell epitopes were CD4+, CD8+ and NK cells. The two latter subsets produced IFN-{gamma} provided CD4+ T cells were present. Since T helper 1 (Th1) cells can mediate an in vivo protective immune response against poliovirus infection in mice, our novel findings in humans merit further detailed characterization of T cells that recognize the enteroviral cross-reactive T cell epitopes.

Received 19 January 1996; accepted 22 April 1996.


This article has been cited by other articles:


Home page
J. Virol.Home page
R. Wahid, M. J. Cannon, and M. Chow
Virus-Specific CD4+ and CD8+ Cytotoxic T-Cell Responses and Long-Term T-Cell Memory in Individuals Vaccinated against Polio
J. Virol., May 15, 2005; 79(10): 5988 - 5995.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
A. Alho, J. Marttila, J. Ilonen, and T. Hyypia
Diagnostic Potential of Parechovirus Capsid Proteins
J. Clin. Microbiol., June 1, 2003; 41(6): 2294 - 2299.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
T. Herremans, J. H. J. Reimerink, T. G. Kimman, H. G. A. M. van der Avoort, and M. P. G. Koopmans
Antibody Responses to Antigenic Sites 1 and 3 of Serotype 3 Poliovirus after Vaccination with Oral Live Attenuated or Inactivated Poliovirus Vaccine and after Natural Exposure
Clin. Vaccine Immunol., January 1, 2000; 7(1): 40 - 44.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1996 by the Society for General Microbiology.